Milan Ferguson presents during the panel session titled ” The value of newborn screening: An SMA case study.”
For more information on this event, click here.
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Milan Ferguson presents during the panel session titled ” The value of newborn screening: An SMA case study.”
For more information on this event, click here.
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...
1 in 4 people globally are already affected by NCDs. By 2030, NCDs will cause 55 million deaths per year under ‘business as usual.’1,2 Effective...
